Safety and Efficacy of Treatment With Once-Daily Ledipasvir/Sofosbuvir (90/400 mg) for 12 Weeks in Genotype 1 HCV-Infected Patients With Severe Renal Impairment

Press/Media: Press / Media

PeriodOct 24 2017

Media coverage

1

Media coverage

  • TitleSafety and Efficacy of Treatment With Once-Daily Ledipasvir/Sofosbuvir (90/400 mg) for 12 Weeks in Genotype 1 HCV-Infected Patients With Severe Renal Impairment
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date10/24/17
    PersonsEric J Lawitz